Nicholas Company Inc. lifted its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 7.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,623,887 shares of the company's stock after acquiring an additional 191,103 shares during the quarter. Nicholas Company Inc. owned approximately 0.14% of Kenvue worth $56,020,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Los Angeles Capital Management LLC bought a new stake in shares of Kenvue during the third quarter valued at approximately $213,000. Victory Capital Management Inc. boosted its position in shares of Kenvue by 66.2% during the third quarter. Victory Capital Management Inc. now owns 1,328,074 shares of the company's stock valued at $30,718,000 after buying an additional 528,849 shares during the period. KBC Group NV grew its position in Kenvue by 114.0% in the 3rd quarter. KBC Group NV now owns 966,160 shares of the company's stock valued at $22,348,000 after acquiring an additional 514,580 shares during the last quarter. Huntington National Bank increased its stake in Kenvue by 26.5% in the third quarter. Huntington National Bank now owns 4,161 shares of the company's stock worth $96,000 after purchasing an additional 871 shares during the period. Finally, Metis Global Partners LLC increased its stake in Kenvue by 1.5% in the third quarter. Metis Global Partners LLC now owns 61,107 shares of the company's stock worth $1,413,000 after purchasing an additional 895 shares during the period. 97.64% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on the stock. UBS Group cut their price target on shares of Kenvue from $23.00 to $21.00 and set a "neutral" rating on the stock in a report on Friday, February 7th. Barclays lowered their price target on Kenvue from $23.00 to $21.00 and set an "equal weight" rating for the company in a report on Friday, January 17th. Piper Sandler increased their target price on shares of Kenvue from $24.00 to $27.00 and gave the stock an "overweight" rating in a report on Monday, February 24th. Citigroup dropped their target price on Kenvue from $25.00 to $21.00 and set a "neutral" rating on the stock in a research report on Wednesday, January 15th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Kenvue from a "buy" rating to a "hold" rating and cut their price objective for the stock from $25.00 to $24.00 in a research report on Thursday, December 12th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, Kenvue has an average rating of "Hold" and an average price target of $23.75.
Check Out Our Latest Research Report on Kenvue
Kenvue Stock Performance
NYSE:KVUE traded down $0.12 during midday trading on Thursday, hitting $23.41. The company's stock had a trading volume of 16,422,006 shares, compared to its average volume of 16,076,596. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $24.46. The firm's 50 day moving average is $21.98 and its 200-day moving average is $22.42. The firm has a market cap of $44.74 billion, a P/E ratio of 44.17, a P/E/G ratio of 2.62 and a beta of 1.25.
Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. Equities analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.
Kenvue Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th were given a $0.205 dividend. The ex-dividend date was Wednesday, February 12th. This represents a $0.82 annualized dividend and a dividend yield of 3.50%. Kenvue's dividend payout ratio (DPR) is 154.72%.
About Kenvue
(
Free Report)
Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
See Also
Before you consider Kenvue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list.
While Kenvue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
